PMC:7534795 / 42980-43065
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T321","span":{"begin":58,"end":66},"obj":"Disease"},{"id":"T322","span":{"begin":67,"end":77},"obj":"Disease"}],"attributes":[{"id":"A321","pred":"mondo_id","subj":"T321","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A322","pred":"mondo_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"x 800 mg (Maes et al., 2020)\n• Sarilumab for hospitalized COVID-19 infections\n• Cytok"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T341","span":{"begin":29,"end":77},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"x 800 mg (Maes et al., 2020)\n• Sarilumab for hospitalized COVID-19 infections\n• Cytok"}
2_test
{"project":"2_test","denotations":[{"id":"33031856-32493441-84038886","span":{"begin":23,"end":27},"obj":"32493441"}],"text":"x 800 mg (Maes et al., 2020)\n• Sarilumab for hospitalized COVID-19 infections\n• Cytok"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1344","span":{"begin":58,"end":66},"obj":"Disease"}],"attributes":[{"id":"A1344","pred":"tao:has_database_id","subj":"1344","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"x 800 mg (Maes et al., 2020)\n• Sarilumab for hospitalized COVID-19 infections\n• Cytok"}